Quality Management System Services
Ensuring your Success from Documentation to Compliance While Transforming for Sustainable Growth by our GMP QMS Services
GMP Quality Management System
GMP QMS Services Built to Meet Regulatory Requirements and Customer Expectations
Zenovel enhances an organization’s performance by boosting customer confidence, increasing sales, and encouraging repeat business. This approach ensures alignment with global regulatory compliance as defined by authorities such as the FDA and the EMA, while also delivering cost-efficient products and services. As a result, organizations are better positioned for sustainable expansion, growth, and profitability, while meeting internal and external regulatory requirements efficiently.
- How do we assist in GMP QMS Setup?
- Elements of Zenovel’s Quality Management System
At Zenovel, our quality management system is a comprehensive approach that aims to meet the needs of an organization and its clients, encompassing various components that should be tailored to each organization’s specific requirements.
- The company objectives and policies for quality
- Quality manual
- Data management
- Internal process
- Client satisfaction with product quality
- Quality evaluation
- Procedures, guidelines and recommendation
- Why Choose Zenovel ?
- Modification Control
We encourage continuous observation and modifications of processes, methods, materials, equipment, and documentation to enhance the safety and quality of finished goods.
- Deviations
Our circulation system ensures that all relevant information, such as product batches and event descriptions, is documented and shared with all relevant parties.
- Client Adherence
People Also Ask (FAQs)
A Quality Management System (QMS) is a structured framework of policies, procedures, and processes used to ensure pharmaceutical products are consistently manufactured and controlled according to quality standards. In GMP environments, a QMS helps organizations meet regulatory requirements while maintaining product safety, effectiveness, and data integrity.
A well-implemented QMS helps pharmaceutical companies maintain regulatory compliance, improve operational efficiency, and ensure consistent product quality. It provides documented processes, risk management systems, and continuous monitoring to prevent errors such as contamination, deviations, or labeling mistakes during manufacturing.
A pharmaceutical QMS typically includes several essential elements such as quality policies and objectives, a quality manual, document and data management systems, internal processes, quality evaluations, and standard operating procedures (SOPs) to ensure consistent manufacturing and regulatory compliance.
Setting up a GMP-compliant QMS generally involves conducting a gap analysis, developing quality policies and SOPs, implementing document control systems, training staff, establishing risk management procedures, and continuously monitoring performance to improve quality processes.
Zenovel provides expert support in establishing and improving GMP-compliant Quality Management Systems by developing quality documentation, implementing structured processes, and aligning systems with global regulatory standards such as FDA and EMA requirements. This helps pharmaceutical companies improve performance, maintain compliance, and build customer confidence.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
